AptarGroup, Inc.
ATR
Rank in Stocks
#2471
AptarGroup, Inc. specializes in developing and manufacturing solutions for... AptarGroup, Inc. specializes in developing and manufacturing solutions for dispensing, sealing, and advanced material science, catering to a broad spectrum of industries such as beauty, personal care, home care, and the pharmaceutical sector (including prescription drugs, consumer health care, and injectables), alongside the food and beverage markets. Its operations are structured into three key segments: Pharma, Beauty + Home, and Food + Beverage. The Pharma division offers critical components for the pharmaceutical industry, including pumps for nasal allergy remedies, metered dose inhaler valves vital for managing respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD), elastomeric primary packaging for injectables, and sophisticated active material science innovations. The Beauty + Home segment primarily supplies the personal care and home care sectors with essential products such as pumps, various closures, aerosol valves, accompanying accessories, and sealing mechanisms. It also furnishes the beauty market with pumps and decorative elements. For the food and beverage industries, its Food + Beverage segment delivers a variety of dispensing and non-dispensing closures, specialized elastomeric flow control components, spray pumps, and aerosol valves. AptarGroup markets its offerings globally, utilizing its internal sales team, complemented by independent representatives and distributors across Asia, Europe, Latin America, and North America. The company is engaged in a strategic partnership with PureCycle Technologies LLC to pioneer the integration of ultra-pure recycled polypropylene into advanced dispensing applications. Additionally, it collaborates with Sonmol on the development of a digital platform providing therapies and services, with a particular focus on respiratory and other health conditions. Established in 1992, AptarGroup, Inc. maintains its corporate headquarters in Crystal Lake, Illinois.
Share Price
$124.90
Market Cap
$7.94B
Change (1 day)
0.13%
Change (1 year)
-3.92%
Country
US
Trade AptarGroup, Inc. (ATR)
Category
Healthcare
P/E ratio for AptarGroup, Inc. (ATR)
P/E ratio as of October 2026 TTM: 21.48
According to AptarGroup, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 21.48. At the end of 2024 the company had a P/E ratio of 27.82.
P/E ratio history for AptarGroup, Inc. from 2000 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 21.48 | 5.23% |
| 2025 | 20.41 | -26.64% |
| 2024 | 27.82 | -2.42% |
| 2023 | 28.51 | -5.15% |
| 2022 | 30.06 | -8.77% |
| 2021 | 32.95 | -20.03% |
| 2020 | 41.20 | 35.75% |
| 2019 | 30.35 | 0.63% |
| 2018 | 30.16 | 23.19% |
| 2017 | 24.48 | 9.11% |
| 2016 | 22.44 | -1.63% |
| 2015 | 22.81 | 0.60% |
| 2014 | 22.67 | -12.99% |
| 2013 | 26.06 | 33.74% |
| 2012 | 19.48 | 3.07% |
| 2011 | 18.90 | 2.36% |
| 2010 | 18.47 | -4.81% |
| 2009 | 19.40 | 24.53% |
| 2008 | 15.58 | -21.52% |
| 2007 | 19.85 | -0.82% |
| 2006 | 20.01 | 8.89% |
| 2005 | 18.38 | -10.15% |
| 2004 | 20.46 | 15.92% |
| 2003 | 17.65 | 5.07% |
| 2002 | 16.80 | -21.39% |
| 2001 | 21.37 | 30.90% |
| 2000 | 16.32 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 47.48 | 121.10% |
US
|
|
| 27.43 | 27.70% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | 164.91% |
US
|
|
| - | - |
CH
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.